Current Development Stage: Hit-to-Lead
CARB-X Investment: Initial investment of US$610k
Initial CARB-X Investment Date: January 16, 2025
CARB-X Investment: Initial investment of US$610k
Initial CARB-X Investment Date: January 16, 2025
Location: Germany
Investors 1
| Date | Name | Website |
| 01.03.2025 | CARB-X | carb-x.org |
Mentions in press and media 7
| Date | Title | Description |
| 12.02.2026 | Nature Microbiology publishes the paper ‘’Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.’’ | Nature Microbiology publishes the paper ‘’Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.’’ Thu, Feb 12, 2026 17:03 CET Report this content This groun... |
| 18.09.2025 | Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025 | With prize money of one million euros, it is one of the most highly endowed medical awards in the world Awarded for groundbreaking pioneering work in cancer therapy using CAR-T cells Award Ceremony with Hessian Prime Minister Boris Rhein GI... |
| 20.11.2024 | The Battle of the Text Editors: LaTeX vs. MS Word | In the world of academic writing, two giants stand tall: LaTeX and Microsoft Word. Each has its own strengths and weaknesses. Choosing between them can feel like picking a side in a battle. This article explores the nuances of both, focusin... |
| 20.11.2024 | LaTeX vs MS.Word: где проще работать с формулами? | Представьте, что вы работаете над научной статьей или диссертацией, в которой очень много формул. Оформление занимает много времени, и бесконечные правки превращают процесс работы в пытку. Это хорошо знакомо многим студентам и научным работ... |
| 26.09.2024 | Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics | Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics Thu, Sep 26, 2024 12:08 CET Report this content Hamlet BioPharma -... |
| 05.06.2024 | Education Cannot Wait's New Climate Champion Adenike Oladosu Calls on World Leaders to Act #RightHereRightNow to Connect Climate Action with Education Action on World Environment Day | 'The interconnected challenges of armed conflicts, forced displacement, environmental degradation and climate change are putting an entire generation at risk. To address the growing education/climate crises, we must act #RightHereRightNow t... |
| 22.09.2021 | Solid Power to Host and Stream “Solid-State of Affairs” Industry Expert Roundtable on October 8, 2021 | LOUISVILLE, Colo., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Solid Power, Inc., an industry-leading developer of all-solid-state battery cells for electric vehicles, in the process of merging with Decarbonization Plus Acquisition Corporation III (... |